Aleth Perdriger Selected Research

Agammaglobulinaemia Tyrosine Kinase

10/2023

Association Between Bruton's Tyrosine Kinase Gene Overexpression and Risk of Lymphoma in Primary Sjögren's Syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Aleth Perdriger Research Topics

Disease

8	Rheumatoid Arthritis 11/2023 - 05/2006
5	Arthritis (Polyarthritis) 01/2022 - 11/2004
4	Fatigue 01/2020 - 02/2014
3	Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis) 03/2024 - 01/2022
3	Infections 01/2022 - 03/2013
3	Inflammation (Inflammations) 03/2015 - 11/2004
2	Sarcoidosis (Schaumann Disease) 12/2020 - 01/2015
2	Pain (Aches) 01/2020 - 07/2014
2	Ankylosing Spondylitis 07/2009 - 01/2008
1	Lymphoma (Lymphomas) 10/2023
1	Giant Cell Arteritis (Horton Disease) 01/2022
1	Symptom Flare Up 10/2021
1	Purpura 07/2021
1	Splenomegaly 07/2021
1	Skin Manifestations 07/2021
1	Back Pain (Backache) 12/2020
1	Sacroiliitis 12/2020
1	Axial Spondyloarthritis 01/2020
1	Lyme Disease (Disease, Lyme) 01/2019
1	Persistent Infection 01/2019
1	Ulcer 01/2019
1	Synovitis 01/2019
1	Telangiectasis (Telangiectasia) 01/2019
1	Interstitial Lung Diseases (Interstitial Lung Disease) 11/2018
1	Arthralgia (Joint Pain) 11/2018
1	Hemochromatosis (Bronze Diabetes) 05/2017
1	Hyperferritinemia 05/2017
1	Hyperuricemia 05/2017
1	Osteoporotic Fractures 05/2016
1	Macrophage Activation Syndrome 07/2015
1	Hepatitis E 07/2015
1	Rheumatic Diseases (Rheumatism) 01/2015
1	Necrosis 07/2014
1	Breast Neoplasms (Breast Cancer) 07/2009
1	Tenosynovitis 12/2008
1	Hypertension (High Blood Pressure) 11/2004

Drug/Important Bio-Agent (IBA)

6	tocilizumab (atlizumab)FDA Link 03/2024 - 03/2015
5	Infliximab (Remicade)FDA Link 01/2020 - 05/2006
4	Rituximab (Mabthera)FDA Link 01/2020 - 03/2013
3	C-Reactive ProteinIBA 03/2024 - 11/2004
3	Antirheumatic Agents (DMARD)IBA 01/2022 - 07/2015
3	AntibodiesIBA 01/2020 - 11/2018
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2016 - 01/2008
3	Monoclonal AntibodiesIBA 03/2015 - 07/2014
2	GlucocorticoidsIBA 03/2024 - 01/2022
2	Methotrexate (Mexate)FDA LinkGeneric 01/2020 - 07/2014
2	Adalimumab (Humira)FDA Link 01/2020 - 01/2015
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2020 - 07/2014
1	Abatacept (Orencia)FDA Link 11/2023
1	LigandsIBA 10/2023
1	Agammaglobulinaemia Tyrosine KinaseIBA 10/2023
1	dimemorfan (AT 17)IBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	Prednisone (Sone)FDA LinkGeneric 01/2022
1	Tumor Necrosis Factor InhibitorsIBA 10/2021
1	gamma-Globulins (gamma-Globulin)IBA 07/2021
1	O,O-diisopropyl-S-benzylthiophosphate (IBP)IBA 12/2020
1	Carbon MonoxideIBA 01/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	RNA Polymerase IIIIBA 11/2018
1	IronIBA 05/2017
1	Ferritins (Ferritin)IBA 05/2017
1	AntioxidantsIBA 05/2017
1	Transferrin (beta 2 Transferrin)IBA 05/2017
1	Uric Acid (Urate)IBA 05/2017
1	A-factor (Streptomyces)IBA 05/2016
1	amsonic acid (DAS)IBA 12/2009
1	ametantrone (HAQ)IBA 12/2009
1	Etanercept (Enbrel)FDA Link 07/2009
1	16S Ribosomal RNAIBA 12/2008
1	Leflunomide (Arava)FDA LinkGeneric 05/2006
1	Azathioprine (Imuran)FDA LinkGeneric 05/2006
1	LipidsIBA 11/2004

Therapy/Procedure

7	Therapeutics 01/2022 - 05/2006
1	Injections 11/2023
1	Self Medication 01/2022
1	Aftercare (After-Treatment) 01/2019
1	Biological Therapy 03/2015